#substudy ผลการค้นหา

🤔Could microvascular resistance explain the acute beneficial effects of #prehospital pulse dose glucocorticoids in #STEMI patients?💔 💡We tried to answer this exact question in our recently published #substudy of the #PULSEMI trial ⬇️ link.springer.com/article/10.118…

Can PCSK9-inhibitor treatment lead to stenosis regression? 🫀 Go read these newly published findings in @EuroInterventio of the prespecified #substudy of the #PACMANAMI-trial co-authored by Prof. @engstr_thomas! #CardioTwitter

Mano namoral pq é tão difícil entrar num subtwt? Eu queria me enturmar no Studio da área de TI mas é difícil ter visibilidade nessa porra #subtwt #substudy #subTI #TI #study #dev #frontend #programação

Our four sub-studies are busy collecting data and developing manuscripts. They are easy to join and involve simple CRF’s – we encourage you to join us. Email [email protected] #COVID19 #covidcritical #substudy #criticalcare #cardiac #neurology #coagulation #kidney

Today we are highlighting Coagulation, our third #substudy. Run by @HeidiDalton26, this #COVID19 study focuses on physiological changes related to hemostasis and the association with bleeding and thrombotic complications. Join today! Email [email protected].

Presenting our second #substudy - Neurological. This study aims to identify type and incidence of neurological complications in #COVID19 #ICU patients. Join study leader @csmfisher. Email [email protected]

Presenting our fourth and final #substudy for the week: Acute Kidney Injury! The #AKI study is looking at the incidence and severity of #COVID19 induced AKI. Join @johnglaffey & @arusmuire in this study: [email protected] @CCRG @NUIGalwayMed @GUH_ICU_Anaesth @ICCCTN

Third in the #substudy line up is the #Coag Study! Focus is on physiologic changes in #COVID patients related to hemostasis and the association with bleeding and thrombotic complications. Join @HeidiDalton26 & @asadusman in their crucial study! [email protected] @CCRG

Second up in #substudy highlight week is the Cardiac Study! Focusing on #cardiac comorbidities and cardiac complications during the hospital admission for #COVID19 patients, you can join the study now! [email protected] @TheRakeshArora @DrGilesPeek @CCRG

#myocardia #substudy #cardiacMR #mavacamtem 5mg vs.Placebo x 30 wks: • #HCM pts ~ LVOTO ≥50 mm Hg • decrease LVmassIndex: -17.4 g/m2 vs. -1.6 g/m2 • decrease LVEF -6.6% vs. -0.3% •decreased LA vol & cardiac biomarkers •No fibrotic changes and maintained nl contractile fn

My @abacbs poster where I will be presenting some work from the @ASPREE_aus #CHIP #SubStudy look forward to hearing the feedback and for any ideas #bioinformaticsMayBring. #shakyVideo #SydneyHereICome #NotOnlyABioinformatician

Exciting announcement: The PADDI Baroreflex Substudy has officially reached its target recruitment of 88 patients. Massive Congratulations to Dr Andy Toner on a mammoth effort with this substudy. @ctn_anzca #clinicaltrials #substudy #anaesthesia #collaboration

The development of a hepatoblastoma biorepository, guidance for sites, challenges & opportunities of this #PHITT #substudy by Stefano Cairo @chilterncollab meeting #samples #freshtissue #cancerresearch #pdx #innovation #newtreatments #partnerships #collaborationinresearch

An overview of @chilterncollab project WP6 - Toxicity of Chemotherapy, by WP6 lead Gareth Veal. #PHITT #Substudy #samples #samplecollection #toxicity #pharmacokinetics #pharmacogenetics #biomarkers

Watch Dr. Ron Waksman interview Dr. Robert Jan van Geuns on the IDEAL-LM trial #substudy at #CRTOnline & on the #app qoo.ly/gfqzd

#myocardia #substudy #cardiacMR #mavacamtem 5mg vs.Placebo x 30 wks: • #HCM pts ~ LVOTO ≥50 mm Hg • decrease LVmassIndex: -17.4 g/m2 vs. -1.6 g/m2 • decrease LVEF -6.6% vs. -0.3% •decreased LA vol & cardiac biomarkers •No fibrotic changes and maintained nl contractile fn

Third in the #substudy line up is the #Coag Study! Focus is on physiologic changes in #COVID patients related to hemostasis and the association with bleeding and thrombotic complications. Join @HeidiDalton26 & @asadusman in their crucial study! [email protected] @CCRG

Presenting our fourth and final #substudy for the week: Acute Kidney Injury! The #AKI study is looking at the incidence and severity of #COVID19 induced AKI. Join @johnglaffey & @arusmuire in this study: [email protected] @CCRG @NUIGalwayMed @GUH_ICU_Anaesth @ICCCTN

Second up in #substudy highlight week is the Cardiac Study! Focusing on #cardiac comorbidities and cardiac complications during the hospital admission for #COVID19 patients, you can join the study now! [email protected] @TheRakeshArora @DrGilesPeek @CCRG

Can PCSK9-inhibitor treatment lead to stenosis regression? 🫀 Go read these newly published findings in @EuroInterventio of the prespecified #substudy of the #PACMANAMI-trial co-authored by Prof. @engstr_thomas! #CardioTwitter

Today we are highlighting Coagulation, our third #substudy. Run by @HeidiDalton26, this #COVID19 study focuses on physiological changes related to hemostasis and the association with bleeding and thrombotic complications. Join today! Email [email protected].

Our four sub-studies are busy collecting data and developing manuscripts. They are easy to join and involve simple CRF’s – we encourage you to join us. Email [email protected] #COVID19 #covidcritical #substudy #criticalcare #cardiac #neurology #coagulation #kidney

Presenting our second #substudy - Neurological. This study aims to identify type and incidence of neurological complications in #COVID19 #ICU patients. Join study leader @csmfisher. Email [email protected]

Here’s how the #COAPT #echofirst #substudy used to grade moderate/severe- almost 15% pts needed more than ERO/PVeins from Asch’s presentation @MedStarHealth #acc19; common dilemma